Recent Advances in Higher-Order, Multimodal, Biomedical Imaging Agents.

Advances in biomedical imaging have spurred the development of integrated multimodal scanners, usually capable of two simultaneous imaging modes. The long-term vision of higher-order multimodality is to improve diagnostics or guidance through the analysis of complementary, data-rich, co-registered images. Synergies achieved through combined modalities could enable researchers to better track diverse physiological and structural events, analyze biodistribution and treatment efficacy, and compare established and emerging modalities. Higher-order multimodal approaches stand to benefit from molecular imaging probes and, in recent years, contrast agents that have hypermodal characteristics have increasingly been reported in preclinical studies. Given the chemical requirements for contrast agents representing various modalities to be integrated into a single entity, the higher-order multimodal agents reported so far tend to be of nanoparticulate form. To date, the majority of reported nanoparticles have included components that are active for magnetic resonance. Herein, recent progress in higher-order multimodal imaging agents is reviewed, spanning a range of material and structural classes, and demonstrating utility in three (or more) imaging modalities.

[1]  Angelique Louie,et al.  Multimodality imaging probes: design and challenges. , 2010, Chemical reviews.

[2]  Yuliang Zhao,et al.  Mesoporous NaYbF4@NaGdF4 core-shell up-conversion nanoparticles for targeted drug delivery and multimodal imaging. , 2014, Biomaterials.

[3]  Jianhua Hao,et al.  PEG modified BaGdF₅:Yb/Er nanoprobes for multi-modal upconversion fluorescent, in vivo X-ray computed tomography and biomagnetic imaging. , 2012, Biomaterials.

[4]  Gang Zheng,et al.  In situ conversion of porphyrin microbubbles to nanoparticles for multimodality imaging. , 2015, Nature nanotechnology.

[5]  S. Gambhir,et al.  Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  Sanjiv S Gambhir,et al.  A molecular imaging primer: modalities, imaging agents, and applications. , 2012, Physiological reviews.

[7]  Dongmei Yang,et al.  Ultra-small BaGdF5-based upconversion nanoparticles as drug carriers and multimodal imaging probes. , 2014, Biomaterials.

[8]  C. Brennan,et al.  A Brain Tumor Molecular Imaging Strategy Using A New Triple-Modality MRI-Photoacoustic-Raman Nanoparticle , 2011, Nature Medicine.

[9]  Taeghwan Hyeon,et al.  Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. , 2009, Chemical Society reviews.

[10]  A. Drzezga,et al.  First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses , 2012, The Journal of Nuclear Medicine.

[11]  Dongmei Wu,et al.  Core-shell NaYF4:Yb3+,Tm3+@FexOy nanocrystals for dual-modality T2-enhanced magnetic resonance and NIR-to-NIR upconversion luminescent imaging of small-animal lymphatic node. , 2011, Biomaterials.

[12]  Xiaohan Liu,et al.  Facile Synthesis of Monodisperse Superparamagnetic Fe3O4 Core@hybrid@Au Shell Nanocomposite for Bimodal Imaging and Photothermal Therapy , 2011, Advanced materials.

[13]  Kai Chen,et al.  PET/NIRF/MRI triple functional iron oxide nanoparticles. , 2010, Biomaterials.

[14]  Jing Zhou,et al.  Gadolinium complex and phosphorescent probe-modified NaDyF4 nanorods for T1- and T2-weighted MRI/CT/phosphorescence multimodality imaging. , 2014, Biomaterials.

[15]  Klaas Nicolay,et al.  Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. , 2009, Accounts of chemical research.

[16]  Sang Moo Lim,et al.  RGD Peptide–Conjugated Multimodal NaGdF4:Yb3+/Er3+ Nanophosphors for Upconversion Luminescence, MR, and PET Imaging of Tumor Angiogenesis , 2013, The Journal of Nuclear Medicine.

[17]  Johan Axelsson,et al.  (68)Ga-labeled superparamagnetic iron oxide nanoparticles (SPIONs) for multi-modality PET/MR/Cherenkov luminescence imaging of sentinel lymph nodes. , 2013, American journal of nuclear medicine and molecular imaging.

[18]  王晓燕 Arch Intern Med:住院增加老年人出院后骨折危险 , 2009 .

[19]  Jonathan F. Lovell,et al.  Emerging applications of porphyrins in photomedicine , 2015, Front. Phys..

[20]  Gang Zheng,et al.  Activatable photosensitizers for imaging and therapy. , 2010, Chemical reviews.

[21]  Lixin Lang,et al.  Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes. , 2012, Biomaterials.

[22]  Z. Dai,et al.  Imaging guided photothermal therapy using iron oxide loaded poly(lactic acid) microcapsules coated with graphene oxide. , 2014, Journal of materials chemistry. B.

[23]  Se-Il Park,et al.  Luminescence imaging using radionuclides: a potential application in molecular imaging. , 2011, Nuclear medicine and biology.

[24]  Yun Sun,et al.  Core-shell lanthanide upconversion nanophosphors as four-modal probes for tumor angiogenesis imaging. , 2013, ACS nano.

[25]  Jinwoo Cheon,et al.  Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. , 2008, Accounts of chemical research.

[26]  N. Beckmann In Vivo magnetic resonance techniques and drug discovery , 2006 .

[27]  R. Misra,et al.  Biomaterials , 2008 .

[28]  Dandan Luo,et al.  Nanomedical engineering: shaping future nanomedicines. , 2015, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[29]  Yeong Su Ha,et al.  Facile preparation of a hybrid nanoprobe for triple-modality optical/PET/MR imaging. , 2010, Small.

[30]  J Nucl Med , 2010 .

[31]  U. Häfeli,et al.  Hyperbranched polyglycerols as trimodal imaging agents: design, biocompatibility, and tumor uptake. , 2012, Bioconjugate chemistry.

[32]  Gang Zheng,et al.  Aggregate enhanced trimodal porphyrin shell microbubbles for ultrasound, photoacoustic, and fluorescence imaging. , 2014, Bioconjugate chemistry.

[33]  Wei Feng,et al.  Gd3+ complex-modified NaLuF4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-Ray computed tomography and magnetic resonance. , 2012, Biomaterials.

[34]  Sanjiv S. Gambhir,et al.  Endoscopic molecular imaging of human bladder cancer using a CD47 antibody , 2014, Science Translational Medicine.

[35]  Chulhong Kim,et al.  Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. , 2011, Nature materials.

[36]  Yuanyi Zheng,et al.  A simple route to prepare monodisperse Au NP-decorated, dye-doped, superparamagnetic nanocomposites for optical, MR, and CT trimodal imaging. , 2013, Small.

[37]  Chulhong Kim,et al.  Porphyrin shell microbubbles with intrinsic ultrasound and photoacoustic properties. , 2012, Journal of the American Chemical Society.

[38]  Tuan Vo-Dinh,et al.  Quintuple-modality (SERS-MRI-CT-TPL-PTT) plasmonic nanoprobe for theranostics. , 2013, Nanoscale.

[39]  W. Huda,et al.  Effective doses in radiology and diagnostic nuclear medicine: a catalog. , 2008, Radiology.

[40]  Chulhong Kim,et al.  Hexamodal Imaging with Porphyrin‐Phospholipid‐Coated Upconversion Nanoparticles , 2015, Advanced materials.

[41]  Yuliang Zhao,et al.  Engineered design of theranostic upconversion nanoparticles for tri-modal upconversion luminescence/magnetic resonance/X-ray computed tomography imaging and targeted delivery of combined anticancer drugs. , 2014, Journal of materials chemistry. B.

[42]  Wei Huang,et al.  Transferring Biomarker into Molecular Probe: Melanin Nanoparticle as a Naturally Active Platform for Multimodality Imaging , 2014, Journal of the American Chemical Society.

[43]  Klaas Nicolay,et al.  Magnetic quantum dots for multimodal imaging. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[44]  Xiu‐Ping Yan,et al.  Incorporation of computed tomography and magnetic resonance imaging function into NaYF4:Yb/Tm upconversion nanoparticles for in vivo trimodal bioimaging. , 2013, Analytical chemistry.

[45]  F. Ståhlberg,et al.  Development of a Hybrid Nanoprobe for Triple-Modality MR/SPECT/Optical Fluorescence Imaging , 2014, Diagnostics.

[46]  Hongying Zhu,et al.  Optical imaging techniques for point-of-care diagnostics. , 2013, Lab on a chip.

[47]  Liangping Zhou,et al.  Radiopaque fluorescence-transparent TaOx decorated upconversion nanophosphors for in vivo CT/MR/UCL trimodal imaging. , 2012, Biomaterials.

[48]  Gang Zheng,et al.  Enzymatic regioselection for the synthesis and biodegradation of porphysome nanovesicles. , 2012, Angewandte Chemie.

[49]  Jonathan F. Lovell,et al.  Porphyrins as Theranostic Agents from Prehistoric to Modern Times , 2012, Theranostics.

[50]  Linda Knutsson,et al.  99mTc-Labeled Superparamagnetic Iron Oxide Nanoparticles for Multimodality SPECT/MRI of Sentinel Lymph Nodes , 2012, The Journal of Nuclear Medicine.

[51]  Sabrina S Wilson Radiology , 1938, Glasgow Medical Journal.

[52]  Yongmin Chang,et al.  Vivid tumor imaging utilizing liposome-carried bimodal radiotracer. , 2014, ACS medicinal chemistry letters.

[53]  L. Mortelmans,et al.  FDG-PET: procedure guidelines for tumour imaging , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[54]  Ralph Weissleder,et al.  Multifunctional magnetic nanoparticles for targeted imaging and therapy. , 2008, Advanced drug delivery reviews.

[55]  Ick Chan Kwon,et al.  Multifunctional nanoparticles for multimodal imaging and theragnosis. , 2012, Chemical Society reviews.

[56]  H. Gu,et al.  Iodinated oil-loaded, fluorescent mesoporous silica-coated iron oxide nanoparticles for magnetic resonance imaging/computed tomography/fluorescence trimodal imaging , 2014, International journal of nanomedicine.

[57]  Hollis G Potter,et al.  Magnetic resonance imaging after total hip arthroplasty: evaluation of periprosthetic soft tissue. , 2004, The Journal of bone and joint surgery. American volume.

[58]  Liangping Zhou,et al.  Single Ho3+‐Doped Upconversion Nanoparticles for High‐Performance T2‐Weighted Brain Tumor Diagnosis and MR/UCL/CT Multimodal Imaging , 2014 .

[59]  Sanjiv S. Gambhir,et al.  Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy , 2009, Proceedings of the National Academy of Sciences.

[60]  Soonhag Kim,et al.  Development of a quadruple imaging modality by using nanoparticles. , 2009, Chemistry.

[61]  Shuai Shao,et al.  Porphyrin–phospholipid liposomes permeabilized by near-infrared light , 2014, Nature Communications.

[62]  D. Miglioretti,et al.  Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. , 2009, Archives of internal medicine.

[63]  Lihong V Wang,et al.  Photoacoustic microscopy and computed tomography: from bench to bedside. , 2014, Annual review of biomedical engineering.

[64]  Yanqing Hua,et al.  Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. , 2012, Biomaterials.

[65]  Jun Lin,et al.  Efficient gene delivery and multimodal imaging by lanthanide-based upconversion nanoparticles. , 2014, Langmuir : the ACS journal of surfaces and colloids.

[66]  Mark F. Lythgoe,et al.  Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging , 2013, Biomaterials.

[67]  Mingyuan Gao,et al.  Magnetic/upconversion fluorescent NaGdF4:Yb,Er nanoparticle-based dual-modal molecular probes for imaging tiny tumors in vivo. , 2013, ACS nano.

[68]  Yun Sun,et al.  Water-stable NaLuF4-based upconversion nanophosphors with long-term validity for multimodal lymphatic imaging. , 2012, Biomaterials.

[69]  J. Willmann,et al.  Molecular imaging in drug development , 2008, Nature Reviews Drug Discovery.

[70]  Claudia Calcagno,et al.  Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. , 2008, Nano letters.

[71]  H. Gerth,et al.  Significant Benefit of Multimodal Imaging: PET/CT Compared with PET Alone in Staging and Follow-up of Patients with Ewing Tumors , 2007, Journal of Nuclear Medicine.

[72]  Simon R. Cherry,et al.  A Smart and Versatile Theranostic Nanomedicine Platform based on Nanoporphyrin , 2014, Nature Communications.

[73]  Jinwoo Cheon,et al.  A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging. , 2008, Angewandte Chemie.

[74]  Z. Fayad,et al.  A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging. , 2010, Contrast Media & Molecular Imaging.

[75]  R. Blasberg,et al.  A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[76]  Weili Lin,et al.  Hybrid silica nanoparticles for multimodal imaging. , 2007, Angewandte Chemie.

[77]  Xueyuan Chen,et al.  Upconversion nanoparticles in biological labeling, imaging, and therapy. , 2010, The Analyst.

[78]  Qian Liu,et al.  Multifunctional rare-earth self-assembled nanosystem for tri-modal upconversion luminescence /fluorescence /positron emission tomography imaging. , 2011, Biomaterials.

[79]  S. Neelamegham,et al.  Functionalization of Cobalt Porphyrin-Phospholipid Bilayers with His-tagged Ligands and Antigens , 2015, Nature chemistry.